Isosorbide mononitrate
Isosorbide mononitrate is a nitrate, a vasodilator (a medicine that widens blood vessels) taken by mouth in the form read here. The US label read, for generic isosorbide mononitrate tablets, lists the prevention and treatment of angina pectoris, chest pain from coronary artery disease. It also says the oral medicine does not act fast enough for the product to be useful in stopping an acute angina episode.
- Drug
- In this atlas
Overview
Technical summary
RxNorm concept 28004 (isosorbide mononitrate, a precise ingredient of the RxNorm ingredient isosorbide, 6057; 28004 is the exact concept because 6057 names the isosorbide base, and RxNorm files isosorbide dinitrate as a separate ingredient, 6058); UNII LX1OH63030. MeSH has no descriptor for isosorbide mononitrate: the exact-label descriptor lookup returned an empty list (a term lookup returned term T126188, which was not used as an identifier). RxClass lists the FDA chemical class Nitrates and the established pharmacologic class Nitrate Vasodilator; the record is filed under the class page Nitrates on that evidence. The label read is the ANI Pharmaceuticals, Inc. generic tablet label, application ANDA075147, effective 2026-03-27 in openFDA (the plan row's set id). The original brand, other generic and repackager labels, and extended-release products were not read. This page records the label indication, the onset sentence and the mechanism sentence only: no trial result and no dose is given.
About this drug
- Level
- Substance
- Mechanism
- The label says the principal pharmacological action of isosorbide mononitrate is relaxation of vascular smooth muscle.
Claims and evidence
Context People with angina pectoris due to coronary artery disease, as described in the US label of generic isosorbide mononitrate tablets
- Recipient
- Recipient not specified
- Population
- Patients with angina pectoris due to coronary artery disease, for prevention and treatment, as the indications section of the label states. The label passages read do not state an age range.
- Care setting
- Prescription medicine, as described in the US label
- Geography
- United States (label of the US Food and Drug Administration)
- Life stage
- Not stated in the label passages read
- Gestational age
- Not reported
- Postnatal age
- Not reported
- Follow-up
- Not applicable (label statement)
Eligibility: 1 inclusion criterion; exclusion criteria not stated
- Included
- Patients with angina pectoris due to coronary artery disease
- Excluded
- None stated
The US label of isosorbide mononitrate tablets (ANI Pharmaceuticals, Inc., application ANDA075147; the version dated 2026-03-27 in openFDA) calls isosorbide mononitrate an organic nitrate and a vasodilator with effects on both arteries and veins. It lists the prevention and treatment of angina pectoris due to coronary artery disease, and says the onset of action of the oral medicine is not sufficiently rapid for the product to be useful in aborting an acute anginal episode.
Applies to Recipient not specified People with angina pectoris due to coronary artery disease, as described in the US label of generic isosorbide mononitrate tablets
- Certainty method
- Not assessed
- Limitations
- This claim records what one US label says the medicine is indicated for and how it describes the medicine. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label is for a generic tablet product; the original brand and other isosorbide mononitrate products were not read. The label passages read state no age range except where the claim says adults. Contraindications, warnings, interactions, use in pregnancy and in children, and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
- Last checked
- 2026-11-18
- Next evidence check due
- Not scheduled
Sources and citations (4)
-
- Locator
- results[0].openfda.application_number[0]
- How it applies
- Application number of the label read.
- Retrieved
- Source effective date
- 2026-03-27
- Source state
- Current
- Version fingerprint
9a7c8ca6b07d747d351d5cc9f76811c56e281caa43fb44ff9e351116b6c7948e- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].effective_time
- How it applies
- Effective date of the label text read.
- Retrieved
- Source effective date
- 2026-03-27
- Source state
- Current
- Version fingerprint
9a7c8ca6b07d747d351d5cc9f76811c56e281caa43fb44ff9e351116b6c7948e- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].indications_and_usage[0]
- How it applies
- Label passage quoted in the research quote table (ISM-LB-04, ISM-LB-05).
- Retrieved
- Source effective date
- 2026-03-27
- Source state
- Current
- Version fingerprint
9a7c8ca6b07d747d351d5cc9f76811c56e281caa43fb44ff9e351116b6c7948e- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
-
- Locator
- results[0].description[0]
- How it applies
- Label passage quoted in the research quote table (ISM-LB-06).
- Retrieved
- Source effective date
- 2026-03-27
- Source state
- Current
- Version fingerprint
9a7c8ca6b07d747d351d5cc9f76811c56e281caa43fb44ff9e351116b6c7948e- Reuse basis
- openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-18, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
Clinical links
Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.
-
Claim, not a settled fact FDA label lists the prevention and treatment of angina pectoris due to coronary artery disease as the indication: Angina pectoris
Applies to Recipient not specified People with angina pectoris due to coronary artery disease, as described in the US label of generic isosorbide mononitrate tablets
The US label of isosorbide mononitrate tablets (ANI Pharmaceuticals, Inc., application ANDA075147; the version dated 2026-03-27 in openFDA) calls isosorbide mononitrate an organic nitrate and a vasodilator with effects on both arteries and veins. It lists the prevention and treatment of angina pectoris due to coronary artery disease, and says the onset of action of the oral medicine is not sufficiently rapid for the product to be useful in aborting an acute anginal episode.Limitations. This claim records what one US label says the medicine is indicated for and how it describes the medicine. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label is for a generic tablet product; the original brand and other isosorbide mononitrate products were not read. The label passages read state no age range except where the claim says adults. Contraindications, warnings, interactions, use in pregnancy and in children, and dosing were not recorded. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
Record details
- Record id
cardio:isosorbide-mononitrate- Content hash
9dc01aae2d1c42cd7286ccdfa8d0e8fd2bbdc1eb7cca2c1d0a205a8ae2e706f1